Avalo Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Avalo Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2014 to Q3 2024.
  • Avalo Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 9.68M shares, a 95% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 9.68M -183M -95% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 1.03M -13M -92.6% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 1.03M -12.2M -92.2% Mar 31, 2024 10-Q/A 2024-07-11
Q4 2023 802K +762K Dec 31, 2023 10-Q 2024-11-07
Q3 2023 192M +183M +1944% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 14M +4.63M +49.2% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 13.2M -99.6M -88.3% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 39.3K* -9.36M Dec 31, 2022 10-K 2024-03-29
Q3 2022 9.41M -103M -91.6% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 9.41M -86.6M -90.2% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 113M +23.7M +26.6% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 9.4M -65.6M -87.5% Dec 31, 2021 10-K 2023-03-29
Q3 2021 112M +37.4M +50% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 96M +21.1M +28.2% Jun 30, 2021 10-Q 2021-08-02
Q1 2021 89.1M +29.5M +49.6% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 75M +30.6M +69% Dec 31, 2020 10-K 2022-03-02
Q3 2020 74.9M +30.8M +69.8% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 74.9M +32M +74.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 59.6M +16.8M +39.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 44.4M +3.58M +8.77% Dec 31, 2019 10-K 2021-03-08
Q3 2019 44.1M +3.43M +8.43% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 42.9M +9.11M +27% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 42.8M +11.3M +36.1% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 40.8M +9.54M +30.5% Dec 31, 2018 10-K 2020-03-11
Q3 2018 40.7M +14.6M +56.1% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 33.8M +19.7M +139% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 31.4M +20.5M +188% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 31.3M +21.8M +231% Dec 31, 2017 10-K 2019-03-18
Q3 2017 26.1M +17M +187% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 14.1M +5.46M +63.2% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 10.9M +2.25M +26% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 9.43M +784K +9.06% Dec 31, 2016 10-K 2018-04-02
Q3 2016 9.08M +8.43M +1297% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 8.65M Jun 30, 2016 10-Q 2016-08-15
Q1 2016 8.65M Mar 31, 2016 10-Q 2016-05-16
Q4 2015 8.65M +8M +1231% Dec 31, 2015 10-K 2017-03-14
Q3 2015 650K Sep 30, 2015 10-Q 2015-11-13
Q4 2014 650K Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.